Ozempic Shortage — Why You Can't Find It
Ben Synth explores why Novo Nordisk couldn't simply make more Ozempic despite skyrocketing demand. This episode reveals the $11 billion manufacturing crisis behind biologic drug production, spanning Denmark, North Carolina, and Brazil, with facility completions stretching to 2029. Discover why making semaglutide resembles precision farming more than traditional manufacturing. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
4 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Ozempic Shortage — Why You Can't Find It!